Brief: Mersana Therapeutics Announces Second Quarter 2023 Financial Results

Mersana Therapeutics

08/08/2023 14:04

Aug 8 (Reuters) - Mersana Therapeutics Inc  MRSN.O :
    * MERSANA THERAPEUTICS ANNOUNCES SECOND QUARTER 2023
FINANCIAL
RESULTS
    * CAPITAL RESOURCES EXPECTED TO SUPPORT CURRENT OPERATING
PLAN
COMMITMENTS INTO 2026
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF
JUNE 30,
2023 WERE $286.6 MILLION
    * QTRLY NET LOSS PER SHARE $0.47
    * Q2 EARNINGS PER SHARE VIEW $-0.44 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbVZJSw 
Further company coverage:  MRSN.O